Compare Medpace Holdings Inc (MEDP) vs Vanguard Total World Stock Index Fund ETF (VT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Vanguard Total World Stock Index Fund ETF — how do they compare? Medpace Holdings Inc trades at $530.58 (market cap $15.08B), while Vanguard Total World Stock Index Fund ETF trades at $155.78. The key difference: Vanguard Total World Stock Index Fund ETF is trading nearer its 52-week high, Medpace Holdings Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | VT | |
|---|---|---|
Market Cap | $15.08B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $620.59 | $159.35 |
52-Week Low | $308.88 | $128.41 |
Enterprise Value | $14.55B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
VT trades at $154.29, down 0.32% on the day, with technical indicators signaling a bearish trend amid neutral oscillators. The ETF's broad global diversification and low expense ratio of 0.06% are key strengths, though financial ratios are not disclosed in the provided data. Recent news highlights comparisons with competing international ETFs, emphasizing VT's comprehensive market exposure.
The outlook remains cautious due to bearish technical signals and competitive pressures from lower-cost alternatives. Risks include expense ratio disadvantages versus peers and global market volatility. Analyst sentiment is mixed, with ongoing debates about optimal international ETF selection influencing investor positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Vanguard Total World Stock Index Fund ETF
VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →
